Back to SYRE
SILVERARC CAPITAL MANAGEMENT, LLC → SYRE
SILVERARC CAPITAL MANAGEMENT, LLC SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$13.5M
Q3 2026
Peak value
$13.5M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $6.2M |
| Q1 2026 | $9.4M |
| Q2 2026 | $5.3M |
| Q3 2026 | $13.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $13.5M | 151.2K | — | — |
| Q2 2026 | $5.3M | 60.0K | — | — |
| Q1 2026 | $9.4M | 186.6K | — | — |
| Q4 2025 | $6.2M | 187.7K | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$383.5M
$377.5M
$348.1M